the impact of the oncotype dx® recurrence score® on treatment decisions in breast cancer patients
Published 8 years ago • 283 plays • Length 5:47Download video MP4
Download video MP3
Similar videos
-
1:33
the impact of the oncotype dx® breast cancer assay on the patient treatment journey
-
1:27
the value of an intermediate recurrence score® result in the oncotype dx® breast cancer assay
-
11:01
the place of the oncotype dx® breast cancer assay in clinical practice
-
8:23
steve shak, asco 2020: the oncotype dx breast recurrence score® test
-
3:15
introducing the oncotype dx® breast cancer assay and its impact in clinical practice
-
4:26
how the oncotype dx test changed treatment decisions for 2 women
-
6:20
predicting late recurrence of breast cancer
-
3:34
experience of the oncotype dx® breast cancer assay in the clinic
-
0:38
the role of the oncotype dx assay in the management of patients with breast cancer
-
2:23
adjuvant chemotherapy use in breast cancer after introducing the oncotype dx® breast cancer assay
-
4:54
role of the oncotype dx breast recurrence score test
-
33:23
oncotype dx breast recurrence score assay after tailorx and rxponder: what’s next?
-
3:57
overview of prospective phase 3 planb trial of 21-gene recurrence score® result in breast cancer
-
2:20
introducing the oncotype dx® breast cancer assay in the clinic
-
2:23
current status and future prospective of trial assigning individualized options for treatment (rx)
-
3:16
assessing the eligibility of a breast cancer patient for genomic testing
-
2:02
oncotype dx for breast cancer
-
2:03
identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
-
2:47
genomic assays impact treatment decisions in patients with er breast cancer